Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant endocrine therapy in premenopausal women with breast cancer.
González Martín A, de la Cruz S, Márquez R. González Martín A, et al. Among authors: marquez r. Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14. Breast Cancer Res Treat. 2010. PMID: 20711666 No abstract available.
[Utility of the PET/CT in vulvar cancer management].
Peiró V, Chiva L, González A, Bratos R, Alonso S, Márquez R, Carballo N, Alonso-Farto JC. Peiró V, et al. Among authors: marquez r. Rev Esp Med Nucl Imagen Mol. 2014 Mar-Apr;33(2):87-92. doi: 10.1016/j.remn.2013.07.009. Epub 2013 Oct 4. Rev Esp Med Nucl Imagen Mol. 2014. PMID: 24095821 Spanish.
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).
Quintela-Fandino M, Urruticoechea A, Guerra J, Gil M, Gonzalez-Martin A, Marquez R, Hernandez-Agudo E, Rodriguez-Martin C, Gil-Martin M, Bratos R, Escudero MJ, Vlassak S, Hilberg F, Colomer R. Quintela-Fandino M, et al. Among authors: marquez r. Br J Cancer. 2014 Sep 9;111(6):1060-4. doi: 10.1038/bjc.2014.397. Epub 2014 Jul 24. Br J Cancer. 2014. PMID: 25058346 Free PMC article. Clinical Trial.
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial.
Quintela-Fandino M, Bueno MJ, Lombardia L, Gil M, Gonzalez-Martin A, Marquez R, Bratos R, Guerra J, Tan E, Lopez A, Colomer R, Salazar R. Quintela-Fandino M, et al. Among authors: marquez r. Mol Oncol. 2014 Dec;8(8):1719-28. doi: 10.1016/j.molonc.2014.07.005. Epub 2014 Jul 17. Mol Oncol. 2014. PMID: 25103625 Free PMC article. Clinical Trial.
Breast metastases from a serous ovarian carcinoma.
Chiva L, Marquez R, Castellanos T. Chiva L, et al. Among authors: marquez r. Int J Gynecol Cancer. 2022 Aug 1;32(8):1086. doi: 10.1136/ijgc-2022-003498. Int J Gynecol Cancer. 2022. PMID: 35914796 No abstract available.
Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program.
Yubero A, Estévez P, Barquín A, Sánchez L, Santaballa A, Pajares B, Reche P, Salvador C, Manso L, Márquez R, González-Martín A. Yubero A, et al. Among authors: marquez r. Gynecol Oncol Rep. 2023 May 24;48:101211. doi: 10.1016/j.gore.2023.101211. eCollection 2023 Aug. Gynecol Oncol Rep. 2023. PMID: 37396679 Free PMC article.
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
Yubero A, Barquín A, Estévez P, Pajares B, Sánchez L, Reche P, Alarcón J, Calzas J, Gaba L, Fuentes J, Santaballa A, Salvador C, Manso L, Herrero A, Taus Á, Márquez R, Madani J, Merino M, Marquina G, Casado V, Constenla M, Gutiérrez M, Dosil A, González-Martín A. Yubero A, et al. Among authors: marquez r. BMC Cancer. 2022 Nov 8;22(1):1150. doi: 10.1186/s12885-022-10191-5. BMC Cancer. 2022. PMID: 36348385 Free PMC article.
253 results